View Clinical Trial (Medical Research Study)
A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1 - NCT00824369-75204(Clinical Trial 264327)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Dallas |
|
State:
|
|
TX |
| Zip Code: |
|
75204 |
| Conditions: |
|
HIV-1 |
| Purpose: |
|
The purpose of the protocol is to assess long-term safety and tolerability of subjects who
discontinue for any reason from UK-453,061 qualifying studies.
|
| Study summary: |
|
To assess long term safety and tolerability of subjects who discontinue for any reason from
UK-453,061 studies. The study will also assess efficacy of the subsequent regimens in these
patients. |
| Criteria: |
|
Inclusion Criteria:
- Previous participation in a qualifying study.
- Male or female at least 18 years of age available for a follow-up period of at least
96 weeks.
Exclusion Criteria:
- Concurrent treatment in another clinical trial.
- Unwilling or unable to be followed for 12 months |
|
|
|
| Study is available at: |
|
Pfizer Investigational Site
Dallas, TX 75204
United States
Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|